logo

For the Inventor, By the Inventor

Yotsukaido, Japan

Akira Iwasa

This inventor holds 24 USPTO granted patents, primarily in Pharmaceutical Formulations. Top assignees: Ss Pharmaceutical Co., Ltd., Dojin Iyaku Kako Co., Ltd., Ssp Co. Ltd. Active years: 1990-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Iwasa. Retrieved from https://idiyas.com/inventor/akira-iwasa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 11

Forward Citations = 318(Granted Patents)


Location History:

  • Yotsukaidoh, JP (1996)
  • Yotsukaido, JP (1990 - 1997)
  • Chiba, JP (1993 - 2002)

Company Filing History:

goldMedal23 out of 90 
 
Ss Pharmaceutical Co., Ltd.
 patents
silverMedal1 out of 7 
 
Dojin Iyaku Kako Co., Ltd.
 patents
bronzeMedal1 out of 27 
 
Ssp Co. Ltd
 patents
4. 1 out of 95 
 
Teikoku Seiyaku Co., Ltd.
 patents
where one patent can have more than one assignee

Years Active: 1990-2002

Loading Chart...
Areas of Expertise:
Sustained Release Tablets
Anti-Inflammatory Gels
Oral Preparations
Piroxicam Tablets
Corticosteroid Ointments
Antidiarrheal Compositions
Vitamin Preparations
Analgesic Plasters
Compressed-Molded Preparations
Antimycotic Preparations
Liquid Preparations
External Adhesive Preparations
24 patents (USPTO):Explore Patents
1. 6441040 - Oral preparations comprising S-(3-hydroxypropyl)-L-cysteine (2002-08-27),
2. 5676970 - Anti-inflammatory analgesic plaster (1997-10-14),
3. 5654002 - Piroxicam tablets and production and process thereof (1997-08-05),
4. 5578600 - Stable liquid preparation of complex vitamin for internal use (1996-11-26),
5. 5500221 - Sustained release suppository (1996-03-19),
6. 5496819 - Antiphlogistic-analgesic plaster comprising triacetin and piroxicam (1996-03-05),
7. 5496561 - Controlled release-initiation and controlled release-rate pharmaceutical (1996-03-05),
8. 5422102 - Antiinflammatory and analgesic gel preparation (1995-06-06),
9. 5405840 - Pranoprofen-containing, suspending medicinal composition (1995-04-11),
10. 5350769 - Antiinflammatory gel preparation (1994-09-27),
11. 5348744 - Antidiarrheal compositions containing loperamide hydrochloride and a (1994-09-20),
12. 5275825 - Compressed-molded preparations (1994-01-04),
13. 5258375 - Composition for the preparation of dosage-form active vitamins D.sub.3 (1993-11-02),
14. 5225206 - Sustained-release pranoprofen preparation (1993-07-06),
15. 5208035 - Diclofenac sodium plaster (1993-05-04),

Title: The Innovative Journey of Akira Iwasa

Introduction: Akira Iwasa, a pioneering inventor hailing from Yotsukaido, Japan, is a remarkable woman who has made significant contributions to the field of technology and innovation.

Latest Patents: Akira Iwasa holds several patents in the realm of electronics and telecommunications, with her most recent inventions focusing on sustainable energy solutions and cutting-edge communication technologies.

Career Highlights: Throughout her illustrious career, Akira Iwasa has been at the forefront of groundbreaking innovations, revolutionizing the way we interact with technology. Her work has not only garnered international acclaim but has also paved the way for future advancements in the industry.

Collaborations: Akira Iwasa has collaborated with leading research institutions, universities, and tech companies to further her research and bring her inventions to life. Her collaborative spirit and dedication to innovation have led to the development of groundbreaking technologies that have reshaped the industry.

Conclusion: In conclusion, Akira Iwasa's passion for innovation, coupled with her relentless drive to push the boundaries of what is possible, has solidified her status as a trailblazing inventor in the world of technology. Her contributions have left an indelible mark on the industry, inspiring future generations to continue pushing the limits of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…